The venture firm, backed by Mayo Clinic for its first fund, is reportedly seeking $350m to $500m for its sophomore vehicle.
Ince Capital, a China-based venture capital firm backed by medical researcher and care provider Mayo Clinic, is close to raising up to $500m for a second fund, Bloomberg has reported. The firm raised $352m for its debut fund in late 2019 from LPs including Mayo Clinic and endowment funds from institutions including the University of…
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.